June 2026
3
CPHI China 2026 took place in Shanghai from June 16 to 18. The grand event brought together global pharmaceutical enterprises and industry elites.Biokong presented its flagship products and cutting-edge innovations, discussing future cooperation opportunities with international partners.
A global leader in tartaric acid production, Baojing showcased premium L(+)-, D(-)- and DL-tartaric acid, alongside its newly developed L-malic acid.
With decades of expertise in chiral organic acids, Bioking demonstrated outstanding strengths in product development, strict quality management and green production.
Our booth attracted crowds of domestic and overseas buyers. Global partners from Europe, Southeast Asia and the Middle East, together with domestic pharma and trading firms, had thorough discussions on application scenarios, quality standards, supply stability and potential collaboration.
To meet personalized demands of different clients, our team delivered professional technical consultations covering pharmaceutical chiral resolution, API production and formulation development. We also had in-depth talks over sample tests, quality systems and supply collaboration, paving the way for further win-win cooperation.
CPHI China serves as not only a vital window for enterprises to showcase strengths, but also a key bridge connecting global partners. Going forward, adhering to innovation-driven development and green manufacturing philosophy, Bioking will keep optimizing product quality and service capabilities. We will further deepen our layout in chiral organic acids, and deliver higher-quality, stable and sustainable product solutions for the global pharmaceutical industry.
